Related Experiment Video
Updated: Jun 20, 2026
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
Identification of survival genes in human glioblastoma cells by small interfering RNA screening
Nikhil G Thaker1, Fang Zhang, Peter R McDonald
1Department of Pharmacology and Chemical Biology, Biomedical Science Tower 3, 3501 Fifth Avenue, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Abstract:
Target identification and validation remain difficult steps in the drug discovery process, and uncovering the core genes and pathways that are fundamental for cancer cell survival may facilitate this process. Glioblastoma represents a challenging form of cancer for chemotherapy. Therefore, we assayed 16,560 short interfering RNA (siRNA) aimed at identifying which of the 5520 unique therapeutically targetable gene products were important for the survival of human glioblastoma. We analyzed the viability of T98G glioma cells 96 h after siRNA transfection with two orthogonal statistical methods and identified 55 survival genes that encoded proteases, kinases, and transferases. It is noteworthy that 22% (12/55) of the survival genes were constituents of the 20S and 26S proteasome subunits. An expression survey of a panel of glioma cell lines demonstrated expression of the proteasome component PSMB4, and the validity of the proteasome complex as a target for survival inhibition was confirmed in a series of glioma and nonglioma cell lines by pharmacological inhibition and RNA interference. Biological networks were built with the other survival genes using a protein-protein interaction network, which identified clusters of cellular processes, including protein ubiquitination, purine and pyrimidine metabolism, nucleotide excision repair, and NF-kappaB signaling. The results of this study should broaden our understanding of the core genes and pathways that regulate cell survival; through either small molecule inhibition or RNA interference, we highlight the potential significance of proteasome inhibition.
Insights
Identifying essential genes for glioblastoma survival is key for drug discovery. This study found proteasome components are critical, highlighting proteasome inhibition as a promising therapeutic strategy for brain cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Target identification and validation are critical yet challenging steps in drug discovery.
- Glioblastoma is a particularly difficult cancer to treat with chemotherapy.
- Identifying core genes and pathways essential for cancer cell survival can streamline drug discovery.
Purpose of the Study:
- To identify therapeutically targetable genes crucial for human glioblastoma cell survival.
- To investigate the role of proteasome subunits in glioblastoma cell viability.
- To explore potential therapeutic strategies targeting identified survival genes.
Main Methods:
- Screening of 16,560 short interfering RNAs (siRNAs) against 5520 unique genes in T98G glioma cells.
- Analysis of cell viability 96 hours post-siRNA transfection using two orthogonal statistical methods.
- Protein-protein interaction network analysis to build biological networks and identify cellular process clusters.
Main Results:
- 55 essential survival genes were identified, including proteases, kinases, and transferases.
- 22% of these survival genes (12 out of 55) were components of the 20S and 26S proteasome.
- Proteasome inhibition via pharmacological agents and RNA interference confirmed its validity as a target for survival inhibition in glioma and non-glioma cell lines.
- Network analysis revealed clusters involved in protein ubiquitination, nucleotide metabolism, DNA repair, and NF-kappaB signaling.
Conclusions:
- The study identifies core genes and pathways regulating glioblastoma cell survival.
- Proteasome inhibition emerges as a significant therapeutic strategy for glioblastoma.
- Findings provide a foundation for developing novel small molecule inhibitors or RNA interference-based therapies for brain cancer.
More Related Videos
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016